Clearly, he knows what he owns. Those who bought high,

New Post Public Reply Private Reply Replies (0) Message Board
Evil Rabbit CaptnAmerca #69436
814
Clearly, he knows what he owns. Those who bought high, panicked and sold, have no clue what Leronlimab is or its potential. Anyone who took a deep dive into the science would be irked by the pullback if they bought at $8, but would sleep well knowing their account will be green soon enough.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sunset World Group: 32 Years of Beachside Legacy

Updated Category News Views 72

Celebrating a Beachside Milestone Out there in the sun-soaked corners of Cancun, it's another sunburnt milestone for the folks over at Sunset Royal Beach Resort. We're talking a full 32 years of greeting guests with their signature tropical flair. Now that's the kind of longevity you just don't find in today's fleeting hospitality market. A pat on the back to any...

Continue Reading
FirstService Unveils New LA Luxury Living Insights

Updated Category News Views 179

Fresh Insights from Los Angeles' Vertical Living Scene FirstService Residential is throwing the spotlight on luxury high-rises in Los Angeles with their latest episode of Skyline Sessions. Catching wind of this release feels like getting the inside scoop from the horse's mouth—it's about the finer points shaping posh city living in a bustling Californian metropolis....

Continue Reading
Tampa General Elevates Lokenauth to CFO Amid Growth

Updated Category News Views 36

Charting New Waters at Tampa General Out here in the blue, the tides of healthcare can swell mighty quick. That's where Tampa General Hospital keeps its anchor firm, announcing Lijah Lokenauth's leap to Executive VP and CFO. If you ask me, it's all about keeping the ship steady—this fella's been steering their financial boat through some hefty waves since 2018....

Continue Reading
OCI Cleared to Merge with Orascom, Sets Delisting Date

Updated Category News Views 131

OCI N.V. has hit a milestone. The shareholders have given the green light to merge with Orascom Construction PLC. This move is fleshed out with an updated roadmap that sharp-eyed investors need to watch closely. The company's shares will no longer be trading on Euronext Amsterdam by late November 2026, contingent on regulatory nods and other variables swirling in the...

Continue Reading
Aurora Innovation Faces Supply Chain Hurdles & Legal Scrutiny

Updated Category News Views 62

Aurora's Rough Road: Production Delays Unveiled You could almost hear the collective groan from investors when Aurora Innovation dropped the bombshell about its truck production delays. You know, after the cheery faces at the Q3 financial results reveal gave way to a rather grim reality check—driverless trucking ain't rolling out quite as planned thanks to those pesky...

Continue Reading
Beta Bionics Faces Class Action Deadline Amid Controversy

Updated Category News Views 16

Beta Bionics' Investors in a Bind: Lead Plaintiff Opportunity Looms Alright, folks, it’s time to size up the situation at Beta Bionics, Inc. (NASDAQ: BBNX). If you're holding onto their stock and nursing some serious losses, you're not alone. The clock's ticking on the November 3, 2026 deadline to step up and lead the charge in a class action lawsuit. What's the Fuss...

Continue Reading
Federal Realty Boosts Outlook with Q3 Gains

Updated Category News Views 14

Numbers That Matter: Solid Q3 Performance Federal Realty Investment Trust's (NYSE: FRT) latest numbers paint a rosy picture—fading the gloom and doom for the moment. The steady climb from $0.69 to $0.74 in diluted EPS from last year is one thing, but it’s the 5.6% boost in Nareit-defined and Core funds from operations per diluted share that's catching eyes, now...

Continue Reading
Nômade Temple Holbox's REVIVAL: A Unique New Year's Eve

Updated Category News Views 42

A Paradise Escape Awaits on New Year's Eve Look, I don't know about you, but I've been through enough hurried holiday seasons to appreciate the slower moments when they come. This year's New Year's Eve at Nômade Temple Holbox, dubbed "REVIVAL," promises just that—a sanctuary by the sea to unwind and renewal as we step into 2027. Step into Island Time Located on the...

Continue Reading
Fintech Shake-Up: OPay's $4B NYSE IPO Arrival

Updated Category News Views 33

It's a big day on Wall Street as OPay dives into the NYSE with a hefty market cap of over $4 billion, signaling a major moment for the fintech arena. Oh, how times are shifting! Today marks the debut of OPay under the ticker 'OPAY,' and let me tell you, there's a buzz in the air that could quicken any seasoned trader's pulse. OPay's Big Day: A New Era of Fintech Their...

Continue Reading
Deciding Between Root Canal or Tooth Extraction

Updated Category News Views 89

The Battle Between Saving and Extracting Teeth No one really talks about teeth as if they hold the keys to happiness, but let’s face it, the difference between chewing a juicy steak and wincing with every bite can be the fate of a single tooth. Dr. Carey Norton from Dacula Family Dentistry breaks down when a root canal can be an oasis of hope and when extraction is the...

Continue Reading

Top 5 Most Recently Viewed Articles

Market Reactions to Federal Reserve's New Projections and Rate Cuts

Updated Category News Views 238

Impact of Federal Reserve Action on Stock Market U.S. stocks experienced a noticeable decline following the Federal Reserve's decision to cut interest rates by a quarter of a percentage point. This move, combined with the central bank's new economic projections suggesting a slower pace of cuts next year, stirred uncertainty among investors. Stocks Surge Ahead of New...

Continue Reading
Maximize Earnings: Earning $500 Monthly with Pfizer Stock

Updated Category News Views 111

Unlocking Earnings Potential with Pfizer Pfizer Inc. (NYSE: PFE) has positioned itself uniquely in the healthcare sector, and as it approaches its third-quarter earnings announcement, many investors are contemplating the opportunities its stock presents. Analysts anticipate that Pfizer will report earnings around 64 cents per share, a decrease compared to $1.06 in the...

Continue Reading
Arteris and AMD Join Forces to Revolutionize AI Chiplet Tech

Updated Category News Views 288

Arteris Inc Partners with AMD for Cutting-Edge AI Chiplet Developments Arteris Inc (NASDAQ: AIP) has made headlines recently with a significant surge in its stock price following a pivotal deal with Advanced Micro Devices Inc (NASDAQ: AMD). The collaboration focuses on next-generation AI chiplet designs, indicating a promising future for both companies in the technology...

Continue Reading
Exploring the Expanding Stain Remover Products Sector

Updated Category News Views 123

Stain Remover Products Market Growth Prospects The stain remover products market is making significant strides, projected to grow from USD 23.33 billion in 2024 to a remarkable USD 37.84 billion by 2034, achieving a compound annual growth rate (CAGR) of 5.0%, as captured in a recent study by Polaris Market Research. Understanding the Stain Remover Products Stain remover...

Continue Reading
PERSUIT and PwC Forge Alliance to Transform Legal Departments

Updated Category News Views 378

PERSUIT and PwC Form Strategic Partnership to Enhance Legal Services PERSUIT, renowned for its innovative legal technology solutions, has announced a strategic alliance with PwC, a global leader in professional services. This collaboration aims to reshape the legal operating model by integrating advanced strategies and technologies to empower legal departments worldwide....

Continue Reading